Suchergebnisse - "Pu, Yedi"

PubPharm (10)

1

Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation

enthalten in: Leukemia | 2024

von Lu, W. | Lyu, H. | Xiao, X. | +23

2

Multi-centers experience using therapeutic plasma exchange for corticosteroid/tocilizumab-refractory cytokine release syndrome following CAR-T therapy

enthalten in: International immunopharmacology | 2024

von Pu, Y. | Zhao, Y. | Qi, Y. | +9

3

Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy

enthalten in: Annals of hematology | 2024

von Zhao, Y. | Zhang, X. | Zhang, M. | +11

4

Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy

enthalten in: Annals of hematology | 2024

von Zhao, Y. | Zhang, X. | Zhang, M. | +11

5

Low-dose administration of prednisone has a good effect on the treatment of prolonged hematologic toxicity post-CD19 CAR-T cell therapy

enthalten in: Frontiers in immunology | 2023

von Wang, J. | Zhang, M. | Lyu, H. | +9

6

The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure

enthalten in: Infection and drug resistance | 2022

von Zhang, M. | Wang, Z. | Wang, J. | +7

7

Metagenomic Next-Generation Sequencing for Diagnostically Challenging Mucormycosis in Patients with Hematological Malignancies

enthalten in: Infection and drug resistance | 2022

von Zhang, M. | Lu, W. | Xie, D. | +6

8

Ibrutinib improves the efficacy of anti-CD19-CAR T-cell therapy in patients with refractory non-Hodgkin lymphoma

enthalten in: Cancer science | 2021

von Liu, M. | Deng, H. | Mu, J. | +5

9

Ibrutinib improves the efficacy of anti‐CD19‐CAR T‐cell therapy in patients with refractory non‐Hodgkin lymphoma

enthalten in: Cancer Science | 2021

von Liu, M. | Deng, H. | Mu, J. | +5

10

Synergistic effect of programmed death-1 inhibitor and programmed death-1 ligand-1 inhibitor combined with chemotherapeutic drugs on DLBCL cell lines in vitro and in vivo

enthalten in: American journal of cancer research | 2020

von Zhang, R. | Lyu, C. | Lu, W. | +3

1
[1]